tafamidis Tablets 20 mg, 61 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #32970
This company is a leading manufacturer of pharmaceutical products, specializing in pellets and granules, tablets, capsules, creams, and ointments. They have a strong track record of success, with GMP certifications from the EU, TGA (Australia), ANVISA (Brazil), and other regulatory bodies. Their expertise extends to multiple therapy areas, leveraging their manufacturing capabilities across various dosage forms. The company caters to a global market, exporting to over 47 countries across regions including North America, South America, Asia, and Europe. They are recognized for their commitment to quality, innovation, and technological advancements in manufacturing processes.